Skip to main content

Closed

EPRX: Eupraxia Pharmaceuticals Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-34.1%

Financially safe

Stretched

Debt / equity0.01×

Interest coverage0.0×

Current ratio19.30×

Eupraxia Pharmaceuticals Inc.

EPRXNASDAQ·USD·Closed

Eupraxia Pharmaceuticals Inc.

EPRXNASDAQ·USD·Closed

$6.40

−2.29%

$6.40

−$0.15 (2.29%)

52W Range

32thpctl

Volume

1.37×avg

Mkt Cap

214.27MUSD

P/E

-6.1TTM

Div Yield

–ann

52W Range

32thpctl

Volume

1.37×avg

Market Cap

214.27MUSD

P/E Ratio

-6.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings